Several biotech companies have rolled out plans to develop vaccines.
This would be to protect against the Wuhan, China coronavirus reports Business Insider.
This move is made with support from global health groups and the US government.
But vaccine development has historically been an arduous, multi-year process.
None of the biotechs provided expected timelines to get their vaccines on the market.
Previous infectious disease outbreaks, including for the Ebola and Zika viruses, took time to develop.
Those vaccines also show the challenges likely to face experimental vaccines for the Chinese Coronavirus.